-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"Pharmaceutical Network Market Analysis" SPD is a new model of hospital and enterprise cooperation in recent years to improve the efficiency of supply chain services in hospitals, which is to centralize the supply, inventory, processing, distribution and other work of medical materials in hospitals, so as to improve the efficiency of medical materials management, reduce costs of a supply chain optimization service.
it is well known that pharmaceutical SPDs were born after pharmacy trusteeship.
in 2018, the National Health and Wellness Commission officially issued a call to stop pharmacy trusteeship, pharmaceutical SPD has become a number of pharmaceutical commercial companies are currently exploring a new model of development.
and comb the major listed pharmaceutical companies in 2020 half-yearly report can be found, currently including China Resources, state control, Kyushua Tong ... Many enterprises have been more or less in the pharmaceutical SPD layout.
As mentioned in Kyusju Tong's semi-annual report for 2020, in providing demand solutions, the company has formed three major product lines: "overall solutions for logistics planning and integration" for pharmaceutical logistics enterprises, "supply chain integration and integrated solutions" for pharmaceutical enterprises, and "hospital supply chain synergy solutions and health information management systems" for hospitals and regional medical management institutions.
, medical supplies procurement, inventory and management software and information systems designed and developed for medical institutions have significant application value in the logistics management of medical supplies and medicines in medical institutions.
China Resources Pharma's 2020 semi-annual report, in the "Prospects and Future Strategy" section also mentioned that the company will strengthen the advantages of the region, optimize the business structure, to build smart pharmaceutical supply chain service providers, from the traditional commercial distribution business to intelligent, professional integrated service providers.
for medical terminals, the company will take the initiative to provide product services, through information technology, specialized services, to help design supply chain management and hospital logistics intelligent integration solutions.
industry insiders believe that many enterprises rush to lay out SPD, meaning that pharmaceutical circulation giants are increasing the layout of business extension, in order to speed up the connection between the upstream and downstream industrial chain, supply chain, change the traditional marketing model, the future SPD model will become more and more hot.
fact, SPD is a reasonable way to make money.
different from hospital-managed pharmacies, pharmaceutical SPD is equivalent to an extension of logistics, is to solve the medical, circulation, manufacturers and patients between the link, reduce medical operating costs, but also want to interconnect the integrated model.
can mainly reduce supply chain costs, so as to achieve reasonable profitability of distribution enterprises.
drugmakers are turning their attention to pharmaceutical SPD supply chain management after the ban on pharmacy trusteeship.
in general, in the context of the ban on pharmacy trusteeship as a trend, in order to improve internal effects and reduce costs, more and more pharmaceutical commercial companies will follow the pace of industry development in the future, engaged in SPD business.
after all, in today's medical reform situation, the era of survival by distribution alone is over.
Among them, it is worth noting that in the case of leading enterprises occupy a larger development advantage, small and medium-sized enterprises may wish to find another way, starting from professional services companies, in DTP business, blood products, medical products, medical supplies and other fields of deep cultivation, and upstream and downstream to reach cooperation stickiness, to create a tailor-made SPD specialization model.